Biotech China 2014

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. Transport of Macromolecules and Effector Cells in Tumor Microcirculation Gordon Conference on Microcirculation, New Hampshire September, 2010
2. Tumor Physiology and Antibody Delivery Society for Nuclear Medicine Annual Meeting, Washington, DC September, 2010
3. Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies Gordon Conference on Drug Delivery, New Hampshire September, 2010
4. Delivery of Novel Therapeutic Agents to Tumors: Microcirculatory Barriers and Strategies International Congress of Mucosal Immunology, Tokyo, Japan September, 2010
5. Determinants of Tumor Blood Flow 15th International Cancer Congress, Hamburg, Germany September, 2010
6. Tumor Microcirculation: Role in Cancer Detection and Treatment 16th European Conference on Microcirculation, Zurich, Switzerland September, 2010
7. Tumor Vascular Architecture and Hemodynamics 16th L.H. Gray Conference on Vasculature as a Target for Anti-Cancer Therapy, Manchester, United Kingdom September, 2010
8. Tumor Angiogenesis and Microcirculation Boston Angiogenesis Meeting, Boston September, 2010
9. Delivery of Genetically Engineered Molecules and Cells in Tumors: Physiological Barriers and Strategies Molecular Therapeutics: Cancer Therapy into the 21st Century, Research Triangle Park, NC September, 2010
10. Tumor Microcirculation International Symposium on Angiogenesis, St. Gallen, Switzerland September, 2010
11. Delivery of Novel Therapeutic Agents in Tumors. Physiological Barriers and Strategies German Nuclear Medicine Society Annual Meeting, Tubingen, Germany September, 2010
12. Interstitial Hypertension in Tumors: Etiology and Therapeutic Implications 9th International Congress of Radiation Research, Toronto, Canada September, 2010
13. Tumor Microcirculation Gordon Conference on Cancer, Newport, RI September, 2010
14. Delivery of Genetically Engineered Molecules and Cells in Tumors: Barriers and Strategies Whitaker Foundation Symposium, Snow Bird, UT September, 2010
15. Transport of Genetically Engineered Molecules and Cells in Tumors 5th World Congress for Microcirculation, Louisville September, 2010
16. Tumor Microcirculation: Both a Barrier and a Target for Cancer Therapy NCI Workshop on Magnetic Resonance Spectroscopy and Tumor Cell Biology September, 2010
17. Tumor Microcirculation - Both a Barrier and a Target for Cancer Therapy Keystone Symposium on Molecular Biology of Endothelial Cells, Keystone September, 2010
18. Delivery of Macromolecules to Normal and Neoplastic Tissues: Problems and Strategies Workshop on Strategies for Delivery of Therapeutic Proteins in Inherited Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda September, 2010
19. Delivery of Therapeutic Agents to Tumors Preuss Foundation Symposium on Delivery of Treatment to Brain Tumors,Dallas September, 2010
20. Tumor Physiology and Drug Delivery Gordon Conference on Chemotherapy of Experimental and Clinical Cancer, New London September, 2010
21. Delivery of Therapeutic Agents to Solid Tumors: Physiological Barriers and Strategies 19th International Symposium on Controlled Release of Bioactive Materials September, 2010
22. Delivery of Genetically Engineered Molecules and Cells to Tumors American Cancer Society’s Seventh Annual Round Table, Charlestown September, 2010
23. Interstitial Pressure in Tumors 41st Annual Radiation Research Society Meeting, Dallas September, 2010
24. Role of Rheology of Cytotoxic Lymphocytes in Immunotherapy The North American Society of Biorheology, New Orleans September, 2010
25. Delivery of Novel Diagnostic and Therapeutic Agents to Tumors: Physiological Considerations workshop on Quantitative Evaluation of Tissue Function with Contrast-Enhanced MRI, National Cancer Institute, Bethesda September, 2010
26. Pharmacokinetics Considerations in Two-Step Therapies of Solid Tumors 10th International Meeting of Advances in the Applications of Monoclonal Antibodies in Clinical Oncology September, 2010
27. Vascular and Interstitial Biology of Solid Tumors Modern Surgical Oncology for the General Surgeon, Deaconess Hospital, Boston September, 2010
28. Delivery of Drugs to Tumors 5th International Liposome Conference, Princeton, NJ September, 2010
29. Convection, Diffusion and Binding in the Tumor Interstitium Gordon Conference on Microcirculation, Plymouth September, 2010
30. How does the Tumor Vasculature Become Arterialized International Union Against Cancer Meeting,” Woods Hole September, 2010
31. Tumor Microcirculation -- Role in Cancer Diagnosis and Treatment 1st Asian Congress for Microcirculation, Osaka September, 2010
32. Delivery of Therapeutic Agents to Solid Tumors Current Concepts in Medical Oncology 1993, Memorial Sloan- Kettering Cancer Center, New York September, 2010
33. Delivery of Antibodies to Solid Tumors: Physiologic and Pharmacokinetic Considerations Fourth International Conference on Antibody Engineering, Coronado September, 2010
34. Extravasation of Proteins In Vivo NIH Vascular Leak Syndrome Workshop, Bethesda September, 2010
35. An In Vivo Look at Microcirculation in Health and Disease Keystone Symposia Conferences on “Inflammation, Growth Regulatory Molecules & Atherosclerosis” and “Molecular Biology of the Endothelial Cell September, 2010
36. Delivery of Therapeutic Agents to Solid Tumors: Role of Vascular and Interstitial Physiology Eight-fifth Annual Meeting of the American Association for Cancer Research, San Francisco September, 2010
37. Vascular and Interstitial Biology of Solid Tumors Modern Surgical Oncology for the General Surgeon, Cambridge September, 2010
38. Interstitial Transport in Tumors: Role of Binding 18th European Conference on Microcirculation, Rome September, 2010
39. Tumor Microcirculation Fifth International Congress of the Metastasis Research Society, Bethesda September, 2010
40. Interstitial Transport: Role of Binding Fifth Conference on Radioimmuno-detection and Radioimmunotherapy of Cancer, Princeton September, 2010
41. Delivery of Novel Therapeutic Agents to Solid Tumors AAPS Ninth Annual Meeting, San Diego, CA September, 2010
42. Intravital Studies of Leukocyte Endothelial Interactions in Tumors MGH-BWH Symposium on Cell Adhesion, Boston September, 2010
43. Physiological Barriers to Transport in Tumors Keystone Symposium on Drug Delivery, Hilton Head Island September, 2010
44. Tumor Microcirculation; Transport in Tumours; Interstitial Transport in Tumours; Scale-Up of Biodistribution from Mouse to Man ICMS Workshop: Tumour Growth and Development, Edinburgh, United Kingdom September, 2010
45. Tumor Angiogenesis and Delivery of Therapeutic Agents to Tumors International Seminar on Controversies in Chemotherapy and Biological Therapy in Cancer, Buenos Aires September, 2010
46. Tumor Angiogenesis and Microcirculation: From Bench to Bedside Frontiers in Medicine Symposium, Venice September, 2010
47. New Insights Into The Structure of Tumor Vasculature: From Fractal Dimensions to Intussusception Congress of Biorheology/2nd Congress on Clinical Hemorheology, Big Sky September, 2010
48. Tumor Microcirculation: Role of Microenvironment Gordon Conference on Angiogenesis and Microcirculation September, 2010
49. Delivery of Effector Cells to Tumors 2nd International Conference on Cellular Engineering September, 2010
50. Leukocyte-Endothelial Interactions in Tumor Microcirculation 31st Annual Meeting of the Society for Leukocyte Biology, Marco Island September, 2010
51. Delivery of Molecules and Cells to Solid Tumors ,” Cap Cure Annual Meeting on Prostate Cancer, Santa Barbara September, 2010
52. Delivery of Molecules and Cells to Solid Tumors BMES Annual Meeting, Boston September, 2010
53. Role of Tumor Physiology in Cancer Therapy Monoclonal Antibodies & Cancer Therapy Symposium, New York, September, 2010
54. Delivery of Molecular Medicine to Solid Tumors: Physiological Barriers and Strategies AACR Special Conference on Cancer: The Interface Between Basic and Applied Research, Baltimore September, 2010
55. Role of Microenvironment in Tumor Angiogenesis and Microcirculation AACR Special Conference on Novel Strategies Against Resistant Cancers, September, 2010
56. Gene Therapy and Brain Tumors The Preuss Foundation, Coronado, CA September, 2010
57. Strategies for Improving Drug Delivery to Solid Tumors Gordon Conference on Drug Carriers in Biology and Medicine, California September, 2010
58. Vascular and Interstitial Physiology of Tumors - Implications for Therapy Isolated Limb and Organ Perfusion Workshop, Berlin September, 2010
59. Physiological Resistance to Treatment of Solid Tumors 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy,” Amsterdam September, 2010
60. Tumor Physiology 87th Annual Meeting of AACR, Washington September, 2010
61. New Perspectives in Microvascular Fluid Exchange: A Hundred Years after Starling The Wellcome Trust, United Kingdom September, 2010
62. Delivery of Molecular Medicine to Solid Tumors Worcester Foundation for Biomedical Research Symposium, Worcester September, 2010
63. Microcirculation and Transport Phenomena in Tumors Wenner-Gren Symposium, Stockholm, Sweden September, 2010
64. Delivery of Molecular Medicine in Solid Tumors Sixth World Congress for Microcirculation, Munich, Germany September, 2010
65. Delivery of Molecular Medicine to Solid Tumors: Physiological Barriers and Strategies NCI Symposium on Renal Carcinoma: Recent Progress and Future Directions, Washington September, 2010
66. Delivery of Molecular Medicine to Solid Tumors Boehringer Ingelheim Fonds International Titisee Conferences, Titisee September, 2010
67. Delivery of Molecular Medicine to Solid Tumors: Pathophysiological Considerations BIOTEC-Congress Symposium, Dusseldorf September, 2010
68. Delivery of Molecular and Cellular Medicine to Solid Tumors Eighth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City September, 2010
69. Delivery of Molecular Medicine to Solid Tumors 22nd Annual Meeting of the Japanese Society for Microcirculation September, 2010
70. Tumor Microcirculation Role in Drug and Nutrient Delivery 1997 - Current Issues in Blood Substitute Research and Development, San Diego September, 2010
71. Cellular and Molecular Basis of Capillary Permeability Experimental Biology 1997 Meeting, New Orleans September, 2010
72. Tumor Microenvironment and Microcirculation: A Dynamic Interplay An International Tumor Microenvironment Workshop, Martha’s Vineyard September, 2010
73. Angiogenesis Suppression by Circulating Angiogenesis Inhibitors Released by PC-3: A New Model Venture Prostate Cancer Retreat, Dedham September, 2010
74. Delivery of Molecular Medicine in Solid Tumors AAPS 1997 Midwest Regional Meeting, Chicago September, 2010
75. Tumor Microcirculation Ninth Pezcoller Symposium, Rovereto, September, 2010
76. Role of VEGF in Vascular Permeability and Adhesion Gordon Conference on Angiogenesis and Microcirculation, Newport, September, 2010
77. Integrative Pathophysiology of Solid Tumors: Role in Detection and Treatment Oncology Frontiers Conference, Hoechst Marion Roussel, Grand Cayman, British West Indies September, 2010
78. Angiogenesis, Vascular Permeability and Leukocyte-Adhesion in Tumors MDACC Annual Basic Science Research Symposium, Houston September, 2010
79. Delivery of Molecular and Cellular Medicine to Solid Tumors AIChE Annual Meeting, Los Angeles September, 2010
80. Tumor Angiogenesis and Microcirculation AACR Special Conference on Angiogenesis and Cancer September, 2010
81. Tumor Angiogenesis and Microcirculation Workshop on Angiogenesis, Toronto September, 2010
82. Delivery of Molecular and Cellular Medicine in Tumors National Institutes of Health Conference on Bioengineering Research: Building the Future of Biology and Medicine September, 2010
83. Tumor Microcirculation Cold Spring Harbor Conference on Pathways to Cancer, Cold Spring Harbor September, 2010
84. Angiogenesis and Microcirculation AACR Annual Meeting, New Orleans, LA September, 2010
85. Angiogenesis and Microcirculation in Tumors: Role of Microenvironment ASIP President’s Symposium on Angiogenesis and Microcirculation, San Francisco September, 2010
86. Tumor Angiogenesis and Microcirculation: Role of Host Organ The Sigrid Juselius Foundation, Helsinki September, 2010
87. Tumor Microenvironment and Microcirculation: Role in Drug Delivery 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam September, 2010
88. Delivery of Molecular and Cellular Medicine to Tumors International Conference on Advances in Biomaterials and Tissue Engineering, Capri September, 2010
89. Tumor Angiogenesis and Microcirculation British Oncological Association Lecture, Nottingham September, 2010
90. Transport in Lymphatics 20th European Conference on Microcirculation, Paris September, 2010
91. The Role of Brain Microenvironment in Vascular Physiology National Institutes of Health, NINDS AIDS Meeting, Alexandria September, 2010
92. Integrative Pathophysiology of Solid Tumors: Novel Techniques and Treatment Relevance Advances in Neuro- Oncology, Boston September, 2010
93. Role of Host-Tumor Interaction on Angiogenesis and Microcirculation Forbeck Foundation Meeting, Hilton Head September, 2010
94. The New Frontier of Molecular Medicine: Delivery of Therapeutics Nature Medicine Meeting on the Molecular Medicine Revolution, Tokyo September, 2010
95. Delivery of Molecular Medicine to Solid Tumors XXXI World Meeting of the International College of Surgeons, Buenos Aires September, 2010
96. Imaging Gene Expression at Cellular Level Quantitative In Vivo Functional Imaging in Oncology, Bethesda September, 2010
97. New Insights into Tumor Angiogenesis and Microenvironment from In Vivo Microscopy Gordon Conference on Radiation Oncology, Ventura September, 2010
98. Tumor Microcirculation AACR Special Conference on Molecular Determinants of Sensitivity to Anti-Tumor Agents, Whistler September, 2010
99. Delivery of Molecular Medicine to Solid Tumors AIMBE Meeting, Washington September, 2010
100. Role of Physiology in Drug Delivery Into Tumors Controlled Release Society, Boston September, 2010
101. Tumor Angiogenesis and Microcirculation 4th Cancer Research Campaign - Beatson International Cancer Conference, Glasgow September, 2010
102. Tumor Angiogenesis and Microcirculation: New Insights Gordon Research Conference on "Angiogenesis and Microcirculation," Salve Regina College, Newport September, 2010
103. In Vivo Microscopy of Gene Expression and Function using Intravital Microscopy Inter-Institute Workshop on In Vivo Optical Imaging, NIH, Bethesda September, 2010
104. Micro-environment and Tumor Angiogenesis 2nd Dutch Association of Gastro-Intestinal Surgery Symposium, Utrecht, The Netherlands September, 2010
105. Tumor Angiogenesis and Microcirculation 13th International Conference on Brain Tumour Research and Therapy, Lake Toya, Hokkaido, September, 2010
106. Tumor Angiogenesis and Microcirculation: Role of Host Microenvironment," 2nd International Symposium on Anti-Angiogenic Agents, Dallas September, 2010
107. Role of Physiology in Drug Delivery into Tumors Gordon Research Conference on Drug Carriers on Medicine and Biology, Ventura September, 2010
108. Role of Host-Tumor Interactions in Angiogenesis and Vascular Function Keystone Symposium on Experimental and Clinical Regulation of Angiogenesis, Salt Lake City September, 2010
109. Imaging Angiogenesis and Vascular Function 91st Annual Meeting of AACR, San Francisco September, 2010
110. Tumor Angiogenesis and Microcirculation: Lessons from In Vivo Microscopy of Gene Expression and Function Eppley Institute Short Course in Cancer Biology, Omaha September, 2010
111. Tumor Angiogenesis and Microcirculation: Role of Host-Tumor Interaction Conference on Vascular Biology of Diabetic Microangiopathy, Var Gard September, 2010
112. In Vivo Molecular and Functional Imaging of Tumors: New Insights from Intravital Microscopy Research Conference on Lasers in Medicine and Biology, New London September, 2010
113. Vascular Heterogeneity in Tumors: Lesson from Intravital Microscopy UICC Study Group Meeting on Basic and Clinical Cancer Research: Tumor Angiogenesis II, Woods Hole September, 2010
114. Tumor Angiogenesis and Microcirculation Gordon Research Conference on Vascular Cell Biology, Plymouth September, 2010
115. Tumor Angiogenesis NCI Epithelial-Stromal Interactions and Tumor Progression Workshop, Bethesda September, 2010
116. Real Time Imaging of Gene Expression and Function in Tumors 42nd Symposium of the Society for Histochemistry, Les Diablerets/Switzerland September, 2010
117. Delivery of Molecular Medicine to Tumors: Lessons from In Vivo Imaging of Gene Expression and Function NIH International Symposium on Tumor-Targeted Delivery Systems, Bethesda September, 2010
118. Tumor Angiogenesis and Microcirculation AACR Special Conference in Cancer Research Angiogenesis & Cancer: From Basic Mechanisms to Therapeutic Applications, Traverse City September, 2010
119. Role of Host-Tumor Interactions in Tumor Angiogenesis and Response to Therapy The 3rd Annual Jack Little Symposium: Genetic and Cellular Factors in Human Cancer Therapy, Boston September, 2010
120. Tumor Angiogenesis and Microcirculation: Role of Host-Tumor Interactions The First Hematology- Oncology/Charlestown Cancer Center Retreat, Boston September, 2010
121. Imaging Gene Expression in Tumors American Society for Therapeutic Radiology and Oncology, Boston September, 2010
122. Imaging Gene Expression, Angiogenesis and Microcirculation in Tumor: Role of Microenvironment Keystone Symposium Cell Migration, Tahoe City September, 2010
123. Tumor Angiogenesis & Therapeutic Response: Role of Host Tumor Interaction American Society of Investigative Pathology at Experimental Biology 2001, Orlando September, 2010
124. Delivery of Therapeutics to Solid Tumors: Role of Host-Tumor Interactions 14th International Research Group in Immunoscintigraphy and Immunotherapy (IRIST) Meeting, Nijmegen September, 2010
125. Tumor Angiogenesis and Vascular Function: Lessons from In-Vivo Imaging Society of Nuclear Medicine Meeting, Toronto September, 2010
126. Tumor Angiogenesis and Vascular Function: Role of Host-Tumor Interactions Gordon Conference Chemotherapy of Experimental and Clinical Cancer, New London September, 2010
127. In Vivo Imaging of Gene Expression, Physiological Function and Therapeutic Response in Tumors Imaging Life: From Cells to Whole Animals, Microscopy Society of America, Long Beach September, 2010
128. Tumor Angiogenesis and Microcirculation Gordon Conference Angiogenesis & Microcirculation September, 2010
129. Leakiness of Tumor Vessels: Functional Abnormalities & Discussion of Blood Vessel Leakiness in Cancer Forbeck Foundation Meeting, Napa Valley September, 2010
130. Tumor Angiogenesis and Microcirculation: New Insights Gordon Conference on Angiogenesis and Microcirculation September, 2010
131. Gene Expression, Angiogenesis and Vascular Function in Tumors: Lessons from Intravital Microscopy International Conference on New Treatments for Brain Tumor: Gene Therapy & Neural Stem Cells, Parma September, 2010
132. Imaging Gene Expression and Function in Tumors: Implications for Angiogenesis and Metastasis AACR/NCI/EORTC International Conference, Miami Beach September, 2010
133. Chemical Engineering and Cancer Medicine in the Post-Genomic Era AIChE Annual Meeting, Reno September, 2010
134. Gene Expression, Angiogenesis and Physiological Function in Tumors: Novel Insights from In Vivo Microscopy 43rd Annual American Society for Therapeutic Radiology and Oncology (ASTRO), San Francisco September, 2010
135. Gene Expression, Angiogenesis and Vascular Function in Tumors: Lessons from Intravital Microscopy 1st Merck Symposium on Advances on Cancer Biotherapy, Barcelona September, 2010
136. Molecular, Anatomic and Functional Imaging of Tumors using Intravital Microscopy Keystone Meeting on Angiogenesis in Cancer and Other Diseases: From Genes to Function to Therapy, Banff September, 2010
137. In Vivo Imaging of Gene Expression, Angiogenesis and Physiological Function in Tumors AACR 93rd Annual Meeting, San Francisco September, 2010
138. Angiogenesis and Lymphangiogenesis in Tumors: New Insights from Intravital Microscopy 67th Cold Spring Harbor Symposium on Quantitative Biology, Cold Spring Harbor September, 2010
139. Lymphatic Metastasis: New Insights International Union Against Cancer Workshop on Metastasis, Woods Hole September, 2010
140. Angiogenesis and Lymphangiogenesis in Tumors: New Insights from Intravital Microscopy 18th UICC Intl Cancer Congress, Oslo September, 2010
141. Intravital Microscopy of Tumors Gordon Conference on Lasers in Biology and Medicine, Meriden September, 2010
142. Angiogenesis and Lymphangiogensis in Tumors: New Insights from Intravital Microscopy First Annual Meeting of the Society for Molecular Imaging, Boston September, 2010
143. Imaging the Inner Workings of Solid Tumors CIMIT Forum, Boston September, 2010
144. Molecular and Physiological Rationale for Combined Anti-angiogenic and Radiation Therapy Gordon Research Conference on Radiation Oncology, Ventura September, 2010
145. Imaging the Inner Workings of Solid Tumors: A Twenty Five Year Odyssey Fourth National Forum on Biomedical Imaging in Oncology, Bethesda September, 2010
146. Angiogenesis and Lymphangiogenesis in Tumors: New Insights from Intravital Microscopy Thirty Years of Angiogenesis Research, Boston September, 2010
147. A Journey through the Inner World of Tumors Modeling and Computers in Cancer Therapy, Turin September, 2010
148. Dissecting Tumor-Host Interactions Using In Vivo Imaging Genes, Environment& Disease, Boston September, 2010
149. Normalizing Tumor Vasculature Using Anti-VEGF Therapy: Pre-Clinical and Clinical Evidence Gordon Research Conference on Angiogenesis and Microcirculation, Newport September, 2010
150. Dissecting tumor angiogenesis and pathophysiology European Cancer Conference, Copenhagen, Denmark September, 2010
151. Angiogenesis and lymphangiogenesis in tumors: New insights from intravital microscopy Keystone Symposium on Angiogenesis, Santa Fe, NM September, 2010
152. Inaugural Robert Bras Lecture - Imaging the Inner Workings of Solid Tumors: A 25 Year Odyssey National Cancer Institute of Canada Meeting on Strategic Directions in Cancer Therapy, Nassau, Bahamas September, 2010
153. Formation and Function of Tumor-Associated Lymphatics Gordon Research Conference on Lymphatics, Ventura September, 2010
154. Tumor as an Aberrant Organ: Insights from Intravital Microscopy 95th Annual Meeting of AACR, Orlando September, 2010
155. Angiogenesis and Lymphangiogenesis in Tumors: New Insights from Intravital Microscopy Annual Meeting of Experimental Biology/ASIP, Washington September, 2010
156. A Journey into the World of Solid Tumors International Conference for Mathematics in Biology and Medicine: Annual Meeting of the Society for Mathematical Biology, Ann Arbor September, 2010
157. Imaging the Inner Workings of Solid Tumors Experimental Genetics of the Laboratory Mouse in Cancer Research, The Jackson Laboratory, Bar Harbor September, 2010
158. Imaging the Inner Workings of Solid Tumors: A 25-Year Odyssey Gordon Conference on Drug Carriers in Medicine and Biology, Blue Sky September, 2010
159. Imaging the Inner Workings of Solid Tumors: A 25-Year Odyssey ARENA Conference, Oslo September, 2010
160. Angiogenesis and Lymphangiogenesis in Tumors: New Insights and Clinical Translation 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Atlanta September, 2010
161. Normalization of Tumor Vasculature and Microenvironment using Anti-Angiogenic Agents NABTT CNS Consortium Meeting, Cleveland September, 2010
162. Imaging the Inner Workings of Solid Tumors Charles River Symposium on Modeling Disease: New Windows on a Hidden World, Harvard Medical School, Boston September, 2010
163. Interactions of Angiogenic Therapy with Cytotoxic Chemotherapy GOG Symposium, San Diego September, 2010
164. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy of Cancer 96th Annual AACR Meeting, Anaheim September, 2010
165. Interstitial Transport in Tumors: Barriers and Strategies 96th Annual AACR Meeting, Anaheim September, 2010
166. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy of Cancer Whitehead Institute Press Seminar, Cambridge September, 2010
167. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy of Cancer Gordon Conference on Angiogenesis and Microcirculation, Newport September, 2010
168. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy of Cancer U.S. Oncology Meeting, Dallas September, 2010
169. Normalization of Tumor Microenvironment: An Emerging Concept in Antiangiogenic Therapy of Cancer 2nd International Conference on Tumor Progression and Drug Resistance, Boston September, 2010
170. Normalization of Tumor Microenvironment by Antiangiogenic Therapy: From Bench to Bedside and Back 13th European Union Gastroenterology Week, Copenhagen September, 2010
171. Normalization of Tumor Vasculature by Antiangiogenic Therapy: From Bench to Bedside and Back AACR Special Meeting on Anti-Angiogenesis and Drug Delivery to Tumors: From Bench to Bedside and Back, Boston September, 2010
172. Normalization of Tumor Microenvironment by Antiangiogenic Therapy: From Bench to Bedside and Back AACR Special Meeting on Cancer, Proteases and Microenvironment Bonita Springs September, 2010
173. Imaging Tumor Vessels and Lymphatics 1st Intl Conference on Vascular Targeting, Cambridge September, 2010
174. Normalization of Tumor Microenvironment by Antiangiogenic Therapy: From Bench to Bedside and Back 8th International Meeting on Anti-Angiogenesis Agents, La Jolla September, 2010
175. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy of Cancer Nature Biotechnology Winter Symposium, Miami September, 2010
176. Normalization of Tumor Microenvironment by Antiangiogenic Therapy: From Bench to Bedside and Back 17th Annul Cancer Progress Conference, New York September, 2010
177. Normalization of Tumor Microenvironment by Antiangiogenic Therapy: From Bench to Bedside and Back 4th International Symposium on Targeted Anticancer Therapies, Amsterdam, the Netherlands September, 2010
178. Normalization of Tumor Microenvironment: An Emerging Concept in Antiangiogenic Therapy of Cancer 97th AACR Annual Meeting, Washington September, 2010
179. Molecular, Cellular, Anatomical and Functional Imaging of Tumors In Vivo: From Bench to Bedside and Back International Symposium on Biomedical Imaging, Washington September, 2010
180. Normalization of Abnormal Vessels: An Emerging Concept in Anti-angiogenic Therapy of Cancer and other Diseases Association for Research in Vision and Ophthalmology (ARVO) 2006 Annual Meeting, Ft. Lauderdale September, 2010
181. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapy: From Bench to Bedside and Back 4th Hematology & Oncology Tumor Targeting Symposium, Melbourne September, 2010
182. Delivery of Nano-Medicine to Solid Tumors: Physiological Barriers and Strategies NCI/NSTI Symposium on Cancer Nanotechnology, Boston September, 2010
183. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapy: From Bench to Bedside and Back Pathways to Progress: Breakthroughs in Targeted Cancer Therapy - an ASCO Satellite Symposium, Atlanta September, 2010
184. Normalization of Tumor Vasculature and Microenvironment Using Targeted Therapies: From Bench to Bedside and Back 18th Pezcoller Symposium on Tumor Microenvironment: Heterotypic Interactions, Trento September, 2010
185. Normalization of Tumor Vasculature by Antiangiogenic Therapy: Implications for Engineering Functional Vasculature Gordon Research Conference on Endothelial Cell Phenotypes in Health and Disease, Biddeford September, 2010
186. Dissecting Steps of Lymphatic Metastasis Gordon Research Conference on Molecular Mechanisms in Lymphatic Function and Disease, Les Diablerets September, 2010
187. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back 10th International Workshop on Tumor Microenvironment: Hypoxia, Angiogenesis and Vasculature, Boston September, 2010
188. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back 4th Annual Angiogenesis and Vascular Targeting Drug Discovery and Development Summit, Boston September, 2010
189. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back 4th Asia Pacific Oncology Summit, Sydne September, 2010
190. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back 5th International Colorectal Cancer Congress, Naples September, 2010
191. Normalization of Tumor Vasculature and Microenvironment Using Targeted Therapies: From Bench to Bedside and Back 37th Princess Takamatsu Cancer Symposium on Cancer Cells and their Microenvironment, Tokyo September, 2010
192. Normalization of Tumor Vasculature and Microenvironment Using Targeted Therapies: From Bench to Bedside and Back 18th Annual Cancer Progress Conference, New York, NY (March 6, 2007). Opening Lecture: “Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back,” National Cancer Institute Early Drug Development Meeting, Washington DC September, 2010
193. Normalization of Tumor Vasculature and Microenvironment Using Targeted Therapies: From Bench to Bedside and Back 40 Years of Metastasis Research: A Symposium in Honor of Dr. Fidler, Houston September, 2010
194. Dissecting the Steps of Lymphatic Metastasis 98th Annual AACR Meeting, Los Angeles September, 2010
195. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back Advances in Oncology, New York September, 2010
196. Normalization of Tumor Vasculature and Microenvironment Using Targeted Therapies: From Bench to Bedside and Back New England NeuroOncology Meeting, Boston September, 2010
197. How to Conduct a Multi-Disciplinary Clinical Trial NCI-Genentech Avastin Summit, Washington September, 2010
198. Vascular Normalization by Antiangiogenic Therapy Days of Molecular Medicine – Nature Medicine Meeting, Boston September, 2010
199. Vascular Normalization as a Mechanism of Antiangiogenic Therapy: Clinical Evidence and Implications ASCO Annual Meeting, Chicago September, 2010
200. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back 25th Beatson International Cancer Meeting, Glasgow, UK September, 2010
201. Creation of Functional Blood Vessels for Cancer Treatment and Tissue Engineering Gordon Research Conference on Biomaterials and Tissue Engineering, Plymouth September, 2010
202. Normalization of Tumor Vasculature: Some New Insights Gordon Research Conference on Angiogenesis and Microcirculation, Newport September, 2010
203. How deos bevacizumab work?,” Novel Agents in the Treatment of Lung Cancer, Fifth Cambridge Conference, Cambridge September, 2010
204. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back,” Boston Glioma Research & Therapy, Boston September, 2010
205. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back International Society of Biological Therapy, Boston September, 2010
206. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back AACR Centennial Conference on Translational Cancer Medicine, Singapore September, 2010
207. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back AACR Meeting on Colon Cancer, Boston September, 2010
208. Lymphangiogenesis and Lymphatic Metastasis 9th Annual Boston Angiogenesis Meeting September, 2010
209. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back Optical Imaging for Medicine and Biology: Applications Cancer, Boston, September, 2010
210. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From Bench to Bedside and Back Eradicating Metastasis, NCI Workshop, Bethesda September, 2010
211. Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: Lessons from Multi- Disciplinary Clinical Trials Canadian Phase I Research Meeting, Ottawa, Canada September, 2010
212. Vascular Biology of Brain Metastasis NCI-Biology of Brain Metastasis Meeting September, 2010
213. Tissue, Circulating and Imaging Biomarkers from Multidisciplinary Translational Trials on Antiangiogenic Therapy of Cancer NCI-CTEP Investigational Drug Steering Committee - Angiogenesis Task Force Meeting, Rockville September, 2010
214. Lessons from Multi-Disciplinary Clinical Trials of Antiangiogenic Therapy of Cancer 99th Annual AACR Meeting, San Diego September, 2010
215. Normalization of Tumor Vasculature and Microenvironment by Targeted Therapies: From Bench to Bedside and Back 4th Protein Engineering Summit, Boston September, 2010
216. Creation of Functional Vasculature for Cancer Treatment and Tissue Engineering Gordon Conference on Signal Transduction by Engineered Extracellular Matrix, Bates College, Lewiston September, 2010
217. Normalization of Tumor Vasculature and Microenvironment Using Targeted Therapies: From Bench to Bedside and Back 35th Annual Meeting of Controlled Release Society, New York September, 2010
218. Deconstructing Solid Tumors Using Intravital Microscopy Gordon Conference on Lasers in Biology and Medicine, Holderness School, Holderness, NH September, 2010
219. Angiogenesis in Brain Tumors 5th Biannual Course on Mechanisms of Neural Differentiation and Brain Tumors, Cold Spring Harbor September, 2010
220. Imaging the Inner Workings of Solid Tumors 17th Annual Course of Experimental Models of Human Cancer, Jackson Lab, Bar Harbor September, 2010
221. Delivery of macromolecules and nanoparticles in tumors Society of Advanced Therapeutics, Boston September, 2010
222. Lessons from multidisciplinary translational trials on antiangiogenic therapy of cancer 50th Annual Meeting of American Society of Therapeutic Radiation Oncology, Boston September, 2010
223. Antiangiogenic Therapy of Brain Tumors 8th Annual Carolyn Frye-Halloran Symposium, Boston September, 2010
224. Normalization of Tumor Vasculature and Microenvironment Using Targeted Therapies: From Bench to Bedside and Back National Cancer Research Institute Annual Meeting, Birmingham, September, 2010
225. Antiangiogenesis: Emerging Paradigms The M. Judah Folkman Conference on Antiangiogenesis: New Frontiers in Therapeutic Development, Cambridge September, 2010
226. Normalization of Tumor Microenvironment for Cancer Treatment AACR Centennial Symposium, Buffalo September, 2010
227. Molecular Markers of Response and Resistance to Angiogenesis Inhibitors ASCO-NCI-EORT Conference on Molecular Markers in Oncology, Hollywood, FL September, 2010
228. Delivery of Nano-Medicine to Solid Tumors: Physiological Barriers and Strategies Materials Research Society, Boston September, 2010
229. Normalization of Tumor Microenvironment for Cancer Treatment: Bench to Bedside and Back NCI Executive Committee Retreat, Bethesda September, 2010
230. Insights from Imaging Tumor Vessels during Antiangiogenic Therapy: Bench to Bedside to Biomarkers 100th Annual AACR Meeting, Denver, September, 2010
231. Delivery of Nanotherapeutics to Tumors: Barriers and Strategies 100th Annual AACR Meeting, Denver September, 2010
232. Normalization of Tumor Microenvironment for Cancer Treatment: Bench to Bedside and Back ASIP Annual Meeting, New Orleans September, 2010
233. Normalization of Tumor Microenvironment: Insights from Intravital Microscopy Nobel Forum on High Resolution In Vivo Imaging of Cell Biology, Stockholm September, 2010
234. Normalization of Tumor Microenvironment for Cancer Treatment: Bench to Bedside and Back The Expanding Role of Angiogenesis in Cancer Therapeutics: The Folkman Legacy, New York Academy of Sciences, Bethesda September, 2010
235. Predictors of Response and Resistance in Antiangiogenic Therapy Annual ASCO Meeting, Orlando, FL September, 2010
236. Anti-angiogenesis Therapy of Cancer: Lessons from Bench and Bedside Gordon Conference on Angiogenesis, Salve Regina University, New Port September, 2010
237. Tumor Angiogenesis and Microenvironment 18th Annual Course of Experimental Models of Human Cancer, Jackson Lab, Bar Harbor September, 2010
238. Angiogenesis and Lymphangiogenesis in Tumors: New Insights from Intravital Microscopy Intl Society for Oncodevelopmental Biology & Medicine, Boston September, 2010



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY AACR Annual Meetings April, 2013
Keynote Efficient Generation of Potent Vasculogenic Cells Stem Cells for Drug Developers March, 2013
Tumor Angiogenesis And Microenvironment 21st Annual Short Course on Experimental Models of Human Cancer August, 2012
Tumor Angiogenesis And Microenvironment 20th Annual Short Course on Experimental Models of Human Cancer August, 2011
Opening Remarks 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers September, 2010
Tumor Microenvironment I: Angiogenesis and Vascular Transport 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers September, 2010
Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapy: from Bench to Bedside to Biomarkers 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers September, 2010
Tumor Microenvironment II: Interstitial and Lymphatic Transport 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers September, 2010
Seed and soil hypothesis revisited Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR September, 2010
Normalizing the Tumor Microenvironment to Improve Drug Delivery and Efficacy 2010 Gastrointestinal Cancers Symposium January, 2010
General Session IV: Molecular Markers of Response and Resistance to Angiogenesis Inhibitors 44th ASCO Annual Meeting November, 2008
Dissecting Steps of Metastasis by Intravital Microscopy Joint Metastasis Research Society-AACR Conference on Metastasis August, 2008
Normalizing Tumor Vessels and Microenvironment to Treat Cancer: From the Bench to Bedside and Back Clinical Development of Therapeutic Antibodies April, 2008
Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From the Bench to Bedside and Back Advances in Breast Cancer Research November, 2007
Plenary Session 6: Clinical Intervention and Populations Outcomes: Global Strategies AACR Centennial Conference: Translational Cancer Medicine November, 2007

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.